The ubiquitin proteasome system - implications for cell cycle control and the targeted treatment of cancer

Biochim Biophys Acta. 2014 Jan;1843(1):150-62. doi: 10.1016/j.bbamcr.2013.02.028. Epub 2013 Mar 1.


Two families of E3 ubiquitin ligases are prominent in cell cycle regulation and mediate the timely and precise ubiquitin-proteasome-dependent degradation of key cell cycle proteins: the SCF (Skp1/Cul1/F-box protein) complex and the APC/C (anaphase promoting complex or cyclosome). While certain SCF ligases drive cell cycle progression throughout the cell cycle, APC/C (in complex with either of two substrate recruiting proteins: Cdc20 and Cdh1) orchestrates exit from mitosis (APC/C(Cdc20)) and establishes a stable G1 phase (APC/C(Cdh1)). Upon DNA damage or perturbation of the normal cell cycle, both ligases are involved in checkpoint activation. Mechanistic insight into these processes has significantly improved over the last ten years, largely due to a better understanding of APC/C and the functional characterization of multiple F-box proteins, the variable substrate recruiting components of SCF ligases. Here, we review the role of SCF- and APC/C-mediated ubiquitylation in the normal and perturbed cell cycle and discuss potential clinical implications of SCF and APC/C functions. This article is part of a Special Issue entitled: Ubiquitin-Proteasome System. Guest Editors: Thomas Sommer and Dieter H. Wolf.

Keywords: APC/C; Cancer; Cell cycle; F-box; SCF complex; Ubiquitin proteasome system.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell Cycle / physiology*
  • Humans
  • Mitosis / physiology
  • Molecular Targeted Therapy / methods*
  • Neoplasms / drug therapy*
  • Proteasome Endopeptidase Complex / physiology*
  • Ubiquitin / physiology*


  • Ubiquitin
  • Proteasome Endopeptidase Complex